Phenolics from Garcinia mangostana alleviate exaggerated vasoconstriction in metabolic syndrome through direct vasodilatation and nitric oxide generation

BMC Complementary and Alternative Medicine

Volumn 16, Issue 1, 2016, Pages

  Abdallah, Hossam M ^a,b   El Bassossy, Hany M ^a,c   Mohamed, Gamal A ^a,d   El halawany, Ali M ^a,b   Alshali, Khalid Z ^e   Banjar, Zainy M ^e  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b CAIRO UNIVERSITY   (Egypt)

^c Zagazig University   (Egypt)

^d Al Azhar University   (Egypt)

^e King Abdulaziz University   (Saudi Arabia)

Author keywords

Benzophenone; Flavonoids; Garcinia mangostana; Metabolic syndrome; Relaxation

Indexed keywords

2,3',4,5',6 PENTAHYDROXY BENZOPHENONE; 2,4,3' TRIHYDROXY BENZOPHENONE 6 O BETA DEXTRO GLUCOPYRANOSIDE; ACETYLCHOLINE; AROMADENDRIN 8 C BETA DEXTRO GLUCOPYRANOSIDE; EPICATECHIN; GARCIMANGOSONE D; GARCINIA MANGOSTANA EXTRACT; INDOMETACIN; MACLURIN 6 O BETA DEXTRO GLUCOPYRANOSIDE(RHODANTHENONE); METHYLENE BLUE; NITRIC OXIDE; PHENOL DERIVATIVE; PHENYLEPHRINE; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; TETRYLAMMONIUM; TOSYLARGININE METHYL ESTER; UNCLASSIFIED DRUG; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG IDENTIFICATION; DRUG STRUCTURE; FRUIT; GARCINIA MANGOSTANA; MALE; METABOLIC SYNDROME X; NONHUMAN; RAT; VASOCONSTRICTION; VASODILATATION; ANIMAL; CHEMISTRY; DRUG EFFECTS; METABOLISM; WISTAR RAT;

ANIMALS; AORTA; GARCINIA MANGOSTANA; MALE; METABOLIC SYNDROME X; NITRIC OXIDE; PHENOLS; PLANT EXTRACTS; PROTECTIVE AGENTS; RATS; RATS, WISTAR; VASOCONSTRICTION; VASODILATION;

EID: 84987597517     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-016-1340-5     Document Type: Article

References (42)

1. Eckel RH, Grundy SM, Zimmet PZ. Metab Synd. Lancet. 2005;365(9468):1415-28.
2. Nisoli E, Clementi E, Carruba MO, Moncada S. Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome? Circul Res. 2007;100(6):795-806.
3. Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes the role of reparatory mechanisms. Diab Care. 2011;34(Supplement 2):S285-90.
4. Patel Timir B, Patel L, Patel Tejas B, Makwana Sunil H, Patel Tushar R, Adeshara S. Effects of atorvastatin as antioxidants in diabetic associated cardiovascular complications. Vascular. 2010;11(12):13-4.
5. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest. 1996;97(11):2601-10.
6. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Brit J Pharmacol. 2000;130(5):963-74.
7. Roman-Ramos R, Flores-Saenz J, Alarcon-Aguilar F. Anti-hyperglycemic effect of some edible plants. J Ethnopharmacol. 1995;48(1):25-32.
8. El Bassossy HM, Hassan NA, Mahmoud MF, Fahmy A. Baicalein protects against hypertension associated with diabetes: effect on vascular reactivity and stiffness. Phytomedicine. 2014;21(12):1742-5.
9. El-Bassossy HM, Abo-Warda SM, Fahmy A. Chrysin and luteolin attenuate diabetes-induced impairment in endothelial-dependent relaxation: Effect on lipid profile, AGEs and NO generation. Phytother Res. 2013;27(11):1678-84.
10. Devalaraja S, Jain S, Yadav H. Exotic fruits as therapeutic complements for diabetes, obesity and metabolic syndrome. Food Res Inter. 2011;44(7):1856-65.
11. Ryu HW, Cho JK, Curtis-Long MJ, Yuk HJ, Kim YS, Jung S, Kim YS, Lee BW, Park KH. α-Glucosidase inhibition and antihyperglycemic activity of prenylated xanthones from Garcinia mangostana. Phytochemistry. 2011;72(17):2148-54.
12. Abdallah H, El-Bassossy H, El-Halawany A, Mohamed G, Alshali K, Banjar Z. PP. 14.02: Psiadia punctulata and Garcinia mangostana have potent vasorelaxant activity on isolated rat aorta. J Hypertension. 2015;33:e246.
13. Abdallah HM, El-Bassossy H, Mohamed GA, El-Halawany AM, Alshali KZ, Banjar ZM. Phenolics from garcinia mangostana inhibit advanced glycation endproducts formation: effect on amadori products, cross-linked structures and protein thiols. Molecules. 2016;21(2):251.
14. Obolskiy D, Pischel I, Siriwatanametanon N, Heinrich M. Garcinia mangostana L.: a phytochemical and pharmacological review. Phytother Res. 2009;23(8):1047-65.
15. Mohamed GA, Ibrahim SR, Shaaban MI, Ross SA. Mangostanaxanthones I and II, new xanthones from the pericarp of Garcinia mangostana. Fitoterapia. 2014;98:215-21.
16. Desoky N, El-Bassossy HM, Fahmy A. Characterization of a rat model of insulin deficiency induced vascular complication. Zagazig Univ Med J. 2014;16(6):569-75.
17. El-Bassossy HM, Elberry AA, Ghareib SA. Geraniol improves the impaired vascular reactivity in diabetes and metabolic syndrome through calcium channel blocking effect. J Diabetes Comp. 2016;30(6):1008-1016.
18. El-Bassossy HM, Dsokey N, Fahmy A. Characterization of vascular complications in experimental model of fructose-induced metabolic syndrome. Toxicol Mech Methods. 2014;24(8):536-43.
19. El-Bassossy HM, El-Fawal R, Fahmy A, Watson ML. Arginase inhibition alleviates hypertension in the metabolic syndrome. Brit J Pharmacol. 2013;169(3):693-703.
20. Ghareib SA, El-Bassossy HM, Elberry AA, Azhar A, Watson ML, Banjar ZM, Alahdal AM. Protective effect of zingerone on increased vascular contractility in diabetic rat aorta. Eur J Pharmacol. 2016;780:174-9.
21. El-Bassossy HM, El-Fawal R, Fahmy A. Arginase inhibition alleviates hypertension associated with diabetes: effect on endothelial dependent relaxation and NO production. Vasc Pharmacol. 2012;57(5-6):194-200.
22. Hassan N, El-Bassossy HM, Zakaria MNM. Heme oxygenase-1 induction protects against hypertension associated with diabetes: effect on exaggerated vascular contractility. Naunyn-Schmied Arch Pharmacol. 2013;386(3):217-26.
23. Ghareib SA, El-Bassossy HM, Elberry AA, Azhar A, Watson ML, Banjar ZM. 6-Gingerol alleviates exaggerated vasoconstriction in diabetic rat aorta through direct vasodilation and nitric oxide generation. Drug Des Dev Ther. 2015;9:6019.
24. El-Bassossy HM, Fahmy A, Badawy D. Cinnamaldehyde protects from the hypertension associated with diabetes. Food Chem Toxicol. 2011;49(11):3007-12.
25. El-Bassossy HM, Abo-Warda SM, Fahmy A. Rosiglitazone, a peroxisome proliferator-activated receptor g stimulant, abrogates diabetes-evoked hypertension by rectifying abnormalities in vascular reactivity. Clin Exper Pharmacol and Physiol. 2012;39(8):643-9.
26. Huang Y-L, Chen C-C, Chen Y-J, Huang R-L, Shieh B-J. Three xanthones and a benzophenone from Garcinia mangostana. J Nat Prod. 2001;64(7):903-6.
27. Sawi SE. A new rare 8-C-glucosylflavonoid and other eight flavonoids from the molluscicidal plant Acacia saligna Wendl. Pharmac Pharmacol Lett. 2001;11(1):30-3.
28. Kaya D, Yalçin FN, Bedir E, Çaliş I, Steinhauser L, Albert K, Ersöz T. New benzophenone glucosides from the aerial parts of Gentiana verna L. subsp. pontica (Soltok.) Hayek. Phytochem Lett. 2011;4(4):459-61.
29. Mabry T, Markham K. The systematic identification of flavonoids. New York: Springer; 1970.
30. Jiang HZ, Quan XF, Tian WX, Hu JM, Wang PC, Huang SZ, Cheng ZQ, Liang WJ, Zhou J, Ma XF. Fatty acid synthase inhibitors of phenolic constituents isolated from Garcinia mangostana. Bioorg Med Chem Lett. 2010;20(20):6045-7.
31. Ansarullah, Bharucha B, Patel V, Ramachandran AV. Oreocnide integrifolia (Gaud.) Miq leaf water extract improves metabolic alterations in high fructose fed insulin resistant and hypertensive rats. Eur J Integ Med. 2010;2(2):79-87.
32. Mansour SM, Bahgat AK, El-Khatib AS, Khayyal MT. Ginkgo biloba extract (EGb 761) normalizes hypertension in 2 K, 1C hypertensive rats: role of antioxidant mechanisms, ACE inhibiting activity and improvement of endothelial dysfunction. Phytomedicine. 2011;18(8-9):641-7.
33. Badawy D, El-Bassossy HM, Fahmy A, Azhar A. Aldose reductase inhibitors zopolrestat and ferulic acid alleviate hypertension associated with diabetes: effect on vascular reactivity. Canad J Physiol and Pharmacol. 2013;91(2):101-7.
34. Iyer SN, Katovich MJ. Vascular reactivity to phenylephrine and angiotensin II in hypertensive rats associated with insulin resistance. Clin Experim Hyperten. 1996;18(2):227-42.
35. Galleano M, Bernatova I, Puzserova A, Balis P, Sestakova N, Pechanova O, Fraga CG. (-)Epicatechin reduces blood pressure and improves vasorelaxation in spontaneously hypertensive rats by NOmediated mechanism. IUBMB Life. 2013;65(8):710-5.
36. Aggio A, Grassi D, Onori E, D'Alessandro A, Masedu F, Valenti M, Ferri C. Endothelium/nitric oxide mechanism mediates vasorelaxation and counteracts vasoconstriction induced by low concentration of flavanols. Eur J Nutr. 2013;52(1):263-72.
37. Steffen Y, Schewe T, Sies H. (-)-Epicatechin elevates nitric oxide in endothelial cells via inhibition of NADPH oxidase. Biochem Biophys Res Commun. 2007;359(3):828-33.
38. Badawy D, El-Bassossy HM, Fahmy A, Azhar A. Aldose reductase inhibitors zopolrestat and ferulic acid alleviate hypertension associated with diabetes: effect on vascular reactivity. Canad J Physiol and Pharmacol. 2012;91(2):101-7.
39. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol. 1998;10(2):248-53.
40. Delbosc S, Paizanis E, Magous R, Araiz C, Dimo T, Cristol J-P, Cros G, Azay J. Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis. 2005;179(1):43-9.
41. Mellor KM, Bell JR, Young MJ, Ritchie RH, Delbridge LM. Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice. J Molec Cell Cardiol. 2011;50(6):1035-43.
42. Khoo NK, Rudolph V, Cole MP, Golin-Bisello F, Schopfer FJ, Woodcock SR, Batthyany C, Freeman BA. Activation of vascular endothelial nitric oxide synthase and heme oxygenase-1 expression by electrophilic nitro-fatty acids. Free Rad Biol Med. 2010;48(2):230-9.